CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $46.37, but opened at $49.21. CochLear shares last traded at $49.21, with a volume of 241 shares.
Analyst Upgrades and Downgrades
CHEOY has been the topic of a number of recent research reports. Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a research note on Thursday, July 16th. Jefferies Financial Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Zacks Research upgraded shares of CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Finally, UBS Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $117.00.
Check Out Our Latest Report on CHEOY
CochLear Stock Performance
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
- Five stocks we like better than CochLear
- Berkshire Just Made a Huge Alphabet Bet—Should You Follow?
- Michael Burry Is Betting Against Palantir Again—Should Investors Care?
- Fabrinet’s Sell-Off May Prove It Is One of AI’s Most Misunderstood Stocks
- Orbiting Wealth: Institutions Load Up SpaceX
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
